Literature DB >> 7733025

Feeding premature newborn infants palmitic acid in amounts and stereoisomeric position similar to that of human milk: effects on fat and mineral balance.

V P Carnielli1, I H Luijendijk, J B van Goudoever, E J Sulkers, A A Boerlage, H J Degenhart, P J Sauer.   

Abstract

The effect of the structure of human milk triglycerides on intestinal fat absorption remains controversial. Twelve infants were each fed, for 1 wk in a crossover design, two formulas that differed only in triglyceride configuration. The "beta" formula contained triglycerides similar to those in human milk (26% palmitic acid, esterified predominantly to the sn-2 position) whereas in the "alpha" formula, which contained triglycerides similar to those in formulas currently marketed, palmitate was mainly at the sn-1,3 positions. Fatty acid, fat, and mineral balances were measured at the end of each 1-wk period. Myristic, palmitic, and stearic acids were absorbed better from the beta formula, but total fat excretion was not reduced. During the feeding of beta formula fecal calcium excretion was lower, urinary calcium higher, and urinary phosphate lower. A formula containing triglycerides similar to those in human milk has significant effects on fatty acid intestinal absorption and improves mineral balance in comparison with a conventional formula.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733025     DOI: 10.1093/ajcn/61.4.1037

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

1.  A randomised controlled study of the effect of long chain polyunsaturated fatty acid supplementation on stool hardness during formula feeding.

Authors:  J S Forsyth; S Varma; M Colvin
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Fat digestion in the neonate.

Authors:  W G Manson; L T Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

3.  Randomised controlled trial of a synthetic triglyceride milk formula for preterm infants.

Authors:  A Lucas; P Quinlan; S Abrams; S Ryan; S Meah; P J Lucas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

Review 4.  Studies on effects of dietary fatty acids as related to their position on triglycerides.

Authors:  J E Hunter
Journal:  Lipids       Date:  2001-07       Impact factor: 1.880

Review 5.  Dietary triacylglycerol structure and its role in infant nutrition.

Authors:  Sheila M Innis
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

6.  Positional analysis of triglycerides and phospholipids rich in long-chain polyunsaturated fatty acids.

Authors:  L Amate; M Ramírez; A Gil
Journal:  Lipids       Date:  1999-08       Impact factor: 1.880

7.  Dietary long-chain PUFA in the form of TAG or phospholipids influence lymph lipoprotein size and composition in piglets.

Authors:  Laura Amate; Angel Gil; María Ramírez
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

8.  Effects of sn-2 palmitic acid-fortified vegetable oil and fructooligosaccharide on calcium metabolism in growing rats fed casein based diet.

Authors:  Yeon-Sook Lee; Eun-Young Kang; Mi-Na Park; You-Young Choi; Jeong-Wook Jeon; Sung-Seob Yun
Journal:  Nutr Res Pract       Date:  2008-03-31       Impact factor: 1.926

9.  Calcium absorption from fortified ice cream formulations compared with calcium absorption from milk.

Authors:  Regine M van der Hee; Silvia Miret; Marieke Slettenaar; Guus S M J E Duchateau; Anton G Rietveld; Joy E Wilkinson; Patricia J Quail; Mark J Berry; Jack R Dainty; Birgit Teucher; Susan J Fairweather-Tait
Journal:  J Am Diet Assoc       Date:  2009-05

10.  High Beta-palmitate formula and bone strength in term infants: a randomized, double-blind, controlled trial.

Authors:  Ita Litmanovitz; Keren Davidson; Alon Eliakim; Rivka H Regev; Tzipora Dolfin; Shmuel Arnon; Fabiana Bar-Yoseph; Amit Goren; Yael Lifshitz; Dan Nemet
Journal:  Calcif Tissue Int       Date:  2012-11-20       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.